Sign In
Buy XLO
Xilio Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -52.54. In total, the insiders bought 27.82M and sold 16.56M XLO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-52.54 |
| ● Buy | 27.82M shares |
| ● Sell | 16.56M shares |
|
74% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Nov 26, 2025 Sell |
Gilead Sciences, Inc. 10 Percent Owner |
13 335 000 Value: $10.00M |
||
|
Nov 26, 2025 Buy |
Gilead Sciences, Inc. 10 Percent Owner |
13 335 000 Value: $1K |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
700 000 Value: $1.95M |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
350 000 Value: $941.5K |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
150 000 Value: $1.90M |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
50 041 Value: $800.7K |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
135 134 Value: $1.58M |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
473 334 Value: $2.79M |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
239 703 Value: $1.32M |
||
|
Nov 21, 2025 Sell |
Russo Rene President And CEO |
100 000 Value: $1.38M |
||
|
Nov 21, 2025 Buy |
Russo Rene President And CEO |
50 041 Value: $75.1K |
||
|
Nov 21, 2025 Buy |
Russo Rene President And CEO |
100 000 Value: $150.0K |
||
|
Nov 21, 2025 Buy |
Russo Rene President And CEO |
135 134 Value: $202.7K |
||
|
Nov 21, 2025 Buy |
Russo Rene President And CEO |
150 000 Value: $225.0K |
||
|
Nov 21, 2025 Sell |
Luptakova Katarina Chief Medical Officer |
106 000 Value: $295.7K |
||
|
Nov 21, 2025 Sell |
Luptakova Katarina Chief Medical Officer |
15 000 Value: $35.6K |
||
|
Nov 21, 2025 Buy |
Luptakova Katarina Chief Medical Officer |
25 000 Value: $37.5K |
||
|
Nov 21, 2025 Buy |
Luptakova Katarina Chief Medical Officer |
44 210 Value: $66.3K |
||
|
Nov 21, 2025 Buy |
Luptakova Katarina Chief Medical Officer |
625 000 Value: $525.6K |
||
|
Nov 21, 2025 Buy |
Frankenfield Christopher James Chief Financial Officer |
20 000 Value: $30.0K |
||
|
Nov 21, 2025 Buy |
Brennan Kevin M. SVP, Finance And Accounting |
20 000 Value: $20.0K |
||
|
Nov 21, 2025 Buy |
Frankenfield Christopher James Chief Financial Officer |
23 786 Value: $35.7K |
||
|
Nov 21, 2025 Buy |
Brennan Kevin M. SVP, Finance And Accounting |
25 000 Value: $25.0K |
||
|
Nov 21, 2025 Buy |
Frankenfield Christopher James Chief Financial Officer |
37 296 Value: $55.9K |
||
|
Nov 21, 2025 Buy |
Frankenfield Christopher James Chief Financial Officer |
45 000 Value: $67.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
